Literature DB >> 24419912

Modulation of neuropathic pain in experimental diabetes mellitus.

Laurentiu Bădescu1, Oana Bădulescu, Manuela Ciocoiu, Magda Bădescu.   

Abstract

The main objective of the current article is to investigate the diabetic polyneuropathy which represents a major preoccupation within the context of high incidence of diabetes mellitus (DM) and its complications. Moreover, neuropathy may develop despite intensive hyperglycaemic control. The effect of Zn and black grape seed polyphenols (BGSP) in streptozotocin diabetic rats was studied. Zn and BGSP were administered by gavage, daily, for 16 weeks to Wistar rats that have been rendered diabetic by a single i.v. injection of streptozotocin (55 mg/kg body weight). Dysalgesia was investigated under the conditions of nociceptive stimulation through the following tests: the thermoalgesic mechanism through the tail-flick test, the hot plate test and the plantar test, and the mechanoalgesic mechanism through the algesimetric test. Thermal hyperalgesia detected in the diabetic group is significantly reduced (p < 0.001) through the administration of polyphenols, or even better, of Zn. Diabetes-associated mechanical hyperalgesia decreased significantly (p < 0.001) probably through the inhibition of the NMDA receptors. Administration of Zn or BGSP to the diabetic group improves glycosylated haemoglobin (HbA1c) values but does not bring them to normal. The present data suggest a favourable effect of Zn and BGSP in inhibiting diabetic complications by several mechanisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24419912     DOI: 10.1007/s13105-013-0309-9

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  38 in total

Review 1.  Oxidative stress and diabetic neuropathy: a new understanding of an old problem.

Authors:  Eva L Feldman
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 2.  New perspectives on the management of diabetic peripheral neuropathic pain.

Authors:  Troels S Jensen; Misha-Miroslav Backonja; Sergio Hernández Jiménez; Solomon Tesfaye; Paul Valensi; Dan Ziegler
Journal:  Diab Vasc Dis Res       Date:  2006-09       Impact factor: 3.291

Review 3.  Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways.

Authors:  A H Khan; J E Pessin
Journal:  Diabetologia       Date:  2002-10-18       Impact factor: 10.122

Review 4.  Antioxidant therapy in acute central nervous system injury: current state.

Authors:  Yossi Gilgun-Sherki; Ziv Rosenbaum; Eldad Melamed; Daniel Offen
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 5.  Flavonoids in food and their health benefits.

Authors:  L H Yao; Y M Jiang; J Shi; F A Tomás-Barberán; N Datta; R Singanusong; S S Chen
Journal:  Plant Foods Hum Nutr       Date:  2004       Impact factor: 3.921

6.  Thiamine deficiency induces endoplasmic reticulum stress in neurons.

Authors:  X Wang; B Wang; Z Fan; X Shi; Z-J Ke; J Luo
Journal:  Neuroscience       Date:  2006-11-28       Impact factor: 3.590

Review 7.  Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.

Authors:  Irina G Obrosova; Ulrich A Julius
Journal:  Curr Vasc Pharmacol       Date:  2005-07       Impact factor: 2.719

Review 8.  Advanced glycation endproducts--role in pathology of diabetic complications.

Authors:  Nessar Ahmed
Journal:  Diabetes Res Clin Pract       Date:  2005-01       Impact factor: 5.602

Review 9.  Polyphenols in foods are more complex than often thought.

Authors:  Véronique Cheynier
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

10.  Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy.

Authors:  Mohamed Talaat Abdel Aziz; Ibrahim Naguib El Ibrashy; Dimitri P Mikhailidis; Ameen Mahmoud Rezq; Mohamed Abdel Aziz Wassef; Hanan Hassan Fouad; Hanan Hosni Ahmed; Dina A Sabry; Heba Mohamed Shawky; Rania Elsayed Hussein
Journal:  Diabetol Metab Syndr       Date:  2013-03-12       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.